FI844804A0 - Foerfarande foer rening av faktorn viii:c. - Google Patents

Foerfarande foer rening av faktorn viii:c.

Info

Publication number
FI844804A0
FI844804A0 FI844804A FI844804A FI844804A0 FI 844804 A0 FI844804 A0 FI 844804A0 FI 844804 A FI844804 A FI 844804A FI 844804 A FI844804 A FI 844804A FI 844804 A0 FI844804 A0 FI 844804A0
Authority
FI
Finland
Prior art keywords
viii
faktorn
foerfarande foer
foer rening
rening
Prior art date
Application number
FI844804A
Other languages
English (en)
Other versions
FI844804L (fi
Inventor
Godfrey A Amphlett
Michael E Hrinda
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Publication of FI844804A0 publication Critical patent/FI844804A0/fi
Publication of FI844804L publication Critical patent/FI844804L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FI844804A 1983-12-05 1984-12-05 Foerfarande foer rening av faktorn viii:c. FI844804L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/557,805 US4508709A (en) 1983-12-05 1983-12-05 Process for purifying factor VIII:C

Publications (2)

Publication Number Publication Date
FI844804A0 true FI844804A0 (fi) 1984-12-05
FI844804L FI844804L (fi) 1985-06-06

Family

ID=24226953

Family Applications (1)

Application Number Title Priority Date Filing Date
FI844804A FI844804L (fi) 1983-12-05 1984-12-05 Foerfarande foer rening av faktorn viii:c.

Country Status (19)

Country Link
US (1) US4508709A (fi)
EP (1) EP0144957B1 (fi)
JP (1) JPS60136518A (fi)
KR (1) KR850004593A (fi)
AT (1) ATE60996T1 (fi)
AU (1) AU569129B2 (fi)
CA (1) CA1248449A (fi)
DE (1) DE3484179D1 (fi)
DK (1) DK162896C (fi)
ES (1) ES538912A0 (fi)
FI (1) FI844804L (fi)
IE (1) IE57644B1 (fi)
IL (1) IL73734A (fi)
IN (1) IN162586B (fi)
MX (1) MX7552E (fi)
NO (1) NO167627C (fi)
NZ (1) NZ210427A (fi)
SG (1) SG14992G (fi)
ZA (1) ZA849434B (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614795A (en) * 1982-08-05 1986-09-30 University Of Rochester Deglycosylated Human Factor VIII:C
US4650858A (en) * 1983-03-21 1987-03-17 Nordisk Gentofte A/S Concentrate of the antihemophilic factor VIII and a process for producing it
ZA852099B (en) * 1984-03-26 1985-12-24 Meloy Lab Recombinant factor viii-c.
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
US4952675A (en) * 1985-02-01 1990-08-28 New York University Method for purifying antihemophilic factor
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
GB2178533B (en) * 1985-07-22 1989-07-19 Asahi Chemical Ind Analytical method of enzyme precursors and device therefor
JPS63108000A (ja) * 1986-05-15 1988-05-12 Green Cross Corp:The 第８因子の精製方法
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
US4795806A (en) * 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
NL8701915A (nl) * 1987-08-14 1989-03-01 Waander Riethorst Adsorbensmateriaal en toepassing daarvan voor het isoleren van stollingsfaktoren.
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
DE3826792C1 (fi) * 1988-08-06 1989-07-06 Biotest Pharma Gmbh, 6072 Dreieich, De
ATE85221T1 (de) * 1988-11-05 1993-02-15 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
FR2665449B1 (fr) * 1990-08-02 1995-04-14 Aquitaine Developp Transf Sang Procede de fabrication de facteur von willebrand ayant une tres haute purete, depourvu en majeure partie de facteur antihemophilique (fviiic), et facteur von willebrand ainsi obtenu, ainsi qu'une composition pharmaceutique le contenant.
FR2644064B1 (fr) * 1989-02-17 1994-05-27 Aquitaine Dev Transf Sanguine Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
GB8913183D0 (en) * 1989-06-08 1989-07-26 Central Blood Lab Authority Chemical products
DE3939346A1 (de) * 1989-11-29 1991-06-06 Behringwerke Ag Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
JPH0427865A (ja) * 1989-12-21 1992-01-30 Kurita Water Ind Ltd 血液凝固因子用分離剤およびその製造方法
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
AU7254894A (en) * 1993-07-23 1995-02-20 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat

Also Published As

Publication number Publication date
EP0144957B1 (en) 1991-02-27
IE57644B1 (en) 1993-02-10
ES8600690A1 (es) 1985-11-01
DE3484179D1 (de) 1991-04-04
ES538912A0 (es) 1985-11-01
DK162896C (da) 1992-05-11
SG14992G (en) 1992-04-16
EP0144957A2 (en) 1985-06-19
FI844804L (fi) 1985-06-06
NO167627C (no) 1991-11-27
JPH0535159B2 (fi) 1993-05-25
KR850004593A (ko) 1985-07-25
IL73734A (en) 1989-09-28
AU3598284A (en) 1985-06-13
DK575184A (da) 1985-06-06
NO844837L (no) 1985-06-06
IN162586B (fi) 1988-06-11
IL73734A0 (en) 1985-03-31
ATE60996T1 (de) 1991-03-15
EP0144957A3 (en) 1987-09-30
DK575184D0 (da) 1984-12-04
NO167627B (no) 1991-08-19
JPS60136518A (ja) 1985-07-20
IE843105L (en) 1985-06-05
NZ210427A (en) 1988-09-29
MX7552E (es) 1989-09-25
CA1248449A (en) 1989-01-10
US4508709A (en) 1985-04-02
ZA849434B (en) 1985-07-31
AU569129B2 (en) 1988-01-21
DK162896B (da) 1991-12-23

Similar Documents

Publication Publication Date Title
FI844804A0 (fi) Foerfarande foer rening av faktorn viii:c.
DK344485D0 (da) Hidtil ukendt behandlingsmetode
DK344585D0 (da) Hidtil ukendt behandlingsmetode
ATE4116T1 (de) Reinigung von menschlichem wachstumshormon.
GB2015531B (en) Purification of bordetella proteins by chromatography
IT1142018B (it) Procedimento per migliorare la stabilita' dei catalizzatori di idro-trattamento catalitico dei tagli petroliferi
HK57092A (en) Treatment of high protein oedemas by direct application of benzo-pyrones
IT1189083B (it) Apparato per irruvidire il margine di tomaie di calzature montate
NO169762C (no) Fremgangsmaate til understoettelse av en isbrytingsprosess
IT1150598B (it) Procedimento per la purificazione della superossidodismutasi mediante cromatografia di affinita'
PL213399A1 (pl) Sposob odwadniania tkanki organicznej
DK508285D0 (da) Lukket intermittent fremgangsmaade til toerring
FI820493L (fi) Foerfarande och anordning foer aptering och uppkapning av stammar
IT8419134A0 (it) Impiego della avilamicina per controllare la dissenteria suina.
KR860000551U (ko) 구조용 파이프의 골조
IT8068390A0 (it) Perfezionamenti ai telai dei carrelli appendice e rimorchietti
IT1228141B (it) Metodo per la produzione concimi composti umificanti bilanciati di pollina e l'eliminazione degli odori per combustione con il recupero del calore
IT8420255A0 (it) Regolo per calcolo dei ritmi biologici inerenti alle persone.
PL204994A1 (pl) Sposob hydroformylowania alfa-olefin
IT7830959A0 (it) Metodo per la cura della psoriasi.
RO74650A2 (ro) Metoda pentru controlul sintezei 2,6-dietil-n-metilenanilinei
IT8222455A0 (it) Processo di frazionamento ad umido per via enzimatica dei componenti i sottoprodotti della macellazione.
IT8333151V0 (it) Ricordino per onorare il trentesimo dei morti
PL211539A1 (pl) Sposob otrzymywania eteru 2-hydroksy-4,2',4'-trojchlodwufenylowego

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: ARMOUR PHARMACEUTICAL COMPANY